SCHEMBL844903

SCHEMBL844903

O=C(Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)COc3cccc(Cl)c3)cc2)cc1)[C@@H]1CCCN1C(=O)COc1cccc(Cl)c1

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
EP300 Q09472 4/20 0.51
CREBBP Q92793 4/20 0.51
CPT2 P23786 3/20 0.50
CPT1A P50416 3/20 0.50
PABPC1 P11940 1/20 0.47
MAPT P10636 1/20 0.46
ALDH1A1 P00352 3/20 0.46
LMNA P02545 1/20 0.46
CFD P00746 1/20 0.46
FKBP1A P62942 1/20 0.45
TSHR P16473 1/20 0.45
HTT P42858 2/20 0.45
MAPK1 P28482 1/20 0.45
F2 P00734 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL873777 0.95 EP300 (0.49) EP300CREBBPCPT2CPT1APABPC1
SCHEMBL10120083 0.92 CPT2 (0.46) EP300CREBBPCPT2CPT1APABPC1
SCHEMBL844882 0.88 PABPC1 (0.59) EP300CREBBPCPT2CPT1APABPC1
SCHEMBL845382 0.82 EP300 (0.52) EP300CREBBPPABPC1ALDH1A1TSHR
SCHEMBL845206 0.80 CYP2C9 (0.52) EP300CREBBPPABPC1ALDH1A1LMNA
SCHEMBL844898 0.77 ALDH1A1 (0.54) EP300CREBBPALDH1A1TSHRHTT
SCHEMBL845251 0.76 PABPC1 (0.50) EP300CREBBPPABPC1ALDH1A1LMNA
SCHEMBL845281 0.76 ALDH1A1 (0.52) EP300CREBBPALDH1A1TSHRHTT
SCHEMBL844900 0.75 CYP2C9 (0.47) EP300CREBBPPABPC1ALDH1A1LMNA
SCHEMBL845519 0.75 ALDH1A1 (0.46) PABPC1ALDH1A1HTTMAPK1F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed